Skip to main content

Multiple Myeloma


Tony Blau, MD, Founder and CEO, provides a demonstration of All4Cure, discusses the vision and need for the platform, and describes its ability to improve patient care.
Daratumumab, lenalidomide, and dexamethasone (DRd) yielded faster and sustained clinically meaningful improvements in…
Special Reports
While there is no cure for MM, a number of treatments are in the research and development pipeline. Clinicians are…
Conference Coverage
Findings from a single center study show that the outpatient setting is safe, effective, and reduces the total length…
Conference Coverage
A recent study assessed the comparative efficacy and cost-effectiveness of daratumumab plus pomalidomide and…
Back to Top